在怀孕期间治疗严重的恶心和吐:病例介绍和建议
Alicia R Khan1, Catherine S Stika2, Katherine L Wisner3,4
1Department of Psychiatry, Medstar Georgetown University Hospital, Washington, DC.
Journal of clinical psychopharmacology
|August 28, 2025
概括
在两名没有对标准抗药反应的住院患者中,米尔塔扎有效治疗了严重的恶心和吐 (sNVP). 这表明米尔塔扎是耐火性sNVP病例的潜在治疗选择.
科学领域:
- 产科和妇科
- 产妇和胎儿医学
- 药理学
背景情况:
- 在怀孕期间严重的恶心和吐 (sNVP) 显著影响母亲和新生儿的健康,治疗选择有限.
- 标准的抗药通常对耐火性sNVP病例无效.
- 在其他疾病中米尔塔扎的疗效和已确定的怀孕安全性使其成为潜在的治疗候选药物.
研究的目的:
- 评估米尔塔扎在治疗严重的恶心和吐 (sNVP) 的疗效和安全性.
- 提供用于产科患者耐性sNVP的初步治疗指南.
主要方法:
- 两名怀孕患者的病例报告 sNVP 耐标准抗药物.
- 治疗包括除了现有的抗疗法外,还需要服用米尔塔扎 (15 mg口服可分解片).
- 在急性治疗阶段和随后的维持阶段对患者进行监测.
主要成果:
- 这两位患者的sNVP症状得到了快速和持续的改善.
- 不需要增加米尔塔扎的剂量.
- 患者能很好地忍受米尔塔扎,副作用很小,其他抗药的服用量也能逐渐减少.
结论:
- 在两名耐火性sNVP的住院患者中,米尔塔扎证明了成功的症状缓解.
- 这一案例系列提供了关于米尔塔扎在产科环境中的使用,逐渐减少和副作用管理的初步建议.
- 需要进一步的研究来证实这些发现并建立最终的治疗方案.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
439
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
439
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Pathophysiology of Vomiting
1.1K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366


